0001642453 false 0001642453 2021-03-18 2021-03-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares





Washington, D.C. 20549





Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934


March 18, 2021

Date of Report (Date of earliest event reported)



(Exact name of registrant as specified in its charter)


Delaware   001-37509   47-3913221
(State or other jurisdiction of


File Number)


(IRS Employer
Identification No.)


15455 Dallas Parkway, Suite 550

Addison, Texas

(Address of Principal Executive Offices)   (Zip Code)


Registrant’s Telephone Number, Including Area Code: (972) 248-0412


Not Applicable

(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)


Securities registered pursuant to Section 12(b) of the Act:


Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   DSKE   The NASDAQ Capital Market


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


¨    Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act   ¨






Item 8.01. Other Events.


As previously disclosed, on December 23, 2020, Daseke, Inc. (the “Company”) entered into a board agreement (the “Don R. Daseke Agreement”) with The Walden Group, Inc. and Don R. Daseke, pursuant to which, among other things, the Company agreed to initiate a share repurchase program to repurchase a minimum of 3,000,000 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), subject to the terms and conditions set forth in the Don R. Daseke Agreement.


On March 18, 2021, the Company’s Board of Directors (the “Board”) approved a stock repurchase program (the “Stock Repurchase Program”) pursuant to which the Company is authorized to repurchase up to 3,000,000 shares of Common Stock. Repurchases under the Stock Repurchase Program may be made, from time to time, in amounts and at prices the Company deems appropriate and may be made pursuant to a trading plan intended to qualify under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Repurchases by the Company under the Stock Repurchase Program will be subject to general market and economic conditions, applicable legal requirements and other considerations, and the Stock Repurchase Program may be suspended, modified or discontinued by the Board at any time without prior notice.


A copy of the press release announcing the Stock Repurchase Program is filed herewith as Exhibit 99.1 and is incorporated herein by reference.


Item 9.01. Financial Statements and Exhibits.


(d) Exhibits.


99.1     Press Release, dated March 22, 2021.
104     Cover Page Interactive Data File (embedded within the Inline XBRL document).







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: March 22, 2021 By: /s/ Soumit Roy
  Name: Soumit Roy

Chief Legal Officer, General Counsel

and Corporate Secretary